| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 663705 | 09550001 | JAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | JAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 2 ml | 25 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09550001/09550001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09550001/09550001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38799 | PIERRE FABRE IBERICA S.A. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 663707 | 09550005 | JAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | JAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 25 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09550005/09550005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09550005/09550005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38799 | PIERRE FABRE IBERICA S.A. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 663730 | 09551002 | VIZARSIN 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VIZARSIN 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos | 25 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09551002/09551002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09551002/09551002_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KERN PHARMA S.L. | 2009-10-29 | 1 | 1 | 1 | 2009-10-29 | 2009-10-29 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 663733 | 09551006 | VIZARSIN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VIZARSIN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos | 50 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09551006/09551006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09551006/09551006_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KERN PHARMA S.L. | 2009-10-29 | 1 | 1 | 1 | 2009-10-29 | 2009-10-29 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 663734 | 09551007 | VIZARSIN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VIZARSIN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 8 comprimidos | 50 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09551007/09551007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09551007/09551007_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KERN PHARMA S.L. | 2009-10-29 | 1 | 1 | 1 | 2009-10-29 | 2009-10-29 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 663735 | 09551008 | VIZARSIN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VIZARSIN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 12 comprimidos | 50 mg | 5 | 12 | 10 | 12 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09551008/09551008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09551008/09551008_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KERN PHARMA S.L. | 2009-10-29 | 1 | 1 | 1 | 2009-10-29 | 2009-10-29 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 663737 | 09551010 | VIZARSIN 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VIZARSIN 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos | 100 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09551010/09551010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09551010/09551010_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KERN PHARMA S.L. | 2009-10-29 | 1 | 1 | 1 | 2009-10-29 | 2009-11-10 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 663738 | 09551011 | VIZARSIN 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VIZARSIN 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 8 comprimidos | 100 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09551011/09551011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09551011/09551011_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KERN PHARMA S.L. | 2009-10-29 | 1 | 1 | 1 | 2009-10-29 | 2009-10-29 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 663739 | 09551012 | VIZARSIN 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VIZARSIN 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 12 comprimidos | 100 mg | 5 | 12 | 10 | 12 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09551012/09551012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09551012/09551012_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KERN PHARMA S.L. | 2009-10-29 | 1 | 1 | 1 | 2009-10-29 | 2009-10-29 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654851 | 09569002 | EXFORGE HCT 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569002/09569002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569002/09569002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664335 | View Edit Delete | |||||||||||
| 654852 | 09569014 | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569014/09569014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569014/09569014_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664336 | View Edit Delete | |||||||||||
| 654853 | 09569026 | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569026/09569026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569026/09569026_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664337 | View Edit Delete | |||||||||||
| 654854 | 09569038 | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569038/09569038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569038/09569038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664338 | View Edit Delete | |||||||||||
| 654860 | 09574002 | DAFIRO HCT 5 mg/160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO HCT 5 mg/160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09574002/09574002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09574002/09574002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2010-03-29 | 1 | 1 | 1 | 2010-03-29 | 2014-03-17 | 0 | 2011-02-24 | 665774 | View Edit Delete | |||||||||||
| 654858 | 09574014 | DAFIRO HCT 10 mg/160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO HCT 10 mg/160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09574014/09574014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09574014/09574014_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2010-03-29 | 1 | 1 | 1 | 2010-04-29 | 2014-03-17 | 0 | 2011-02-24 | 665775 | View Edit Delete | |||||||||||
| 654861 | 09574026 | DAFIRO HCT 5 mg/160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO HCT 5 mg/160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09574026/09574026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09574026/09574026_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2010-03-29 | 1 | 1 | 1 | 2010-03-29 | 2014-03-17 | 0 | 2011-02-24 | 665776 | View Edit Delete | |||||||||||
| 654859 | 09574038 | DAFIRO HCT 10 mg/160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO HCT 10 mg/160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09574038/09574038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09574038/09574038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2010-03-29 | 1 | 1 | 1 | 2010-03-29 | 2014-03-17 | 0 | 2011-02-24 | 665777 | View Edit Delete | |||||||||||
| 663884 | 09576003 | IRBESARTAN TEVA 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN TEVA 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 75 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09576003/09576003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09576003/09576003_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2010-02-16 | 1 | 1 | 1 | 2010-02-16 | 2010-02-16 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 663885 | 09576016 | IRBESARTAN TEVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN TEVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09576016/09576016_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09576016/09576016_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2010-02-16 | 1 | 1 | 1 | 2010-02-16 | 2010-02-16 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 663886 | 09576029 | IRBESARTAN TEVA 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN TEVA 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 300 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09576029/09576029_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09576029/09576029_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2010-02-16 | 1 | 1 | 1 | 2010-02-16 | 2010-02-16 | 1 | 2011-10-24 | View Edit Delete |
Page 38 of 1035, showing 20 records out of 20697 total, starting on record 741, ending on 760